Delox is a pioneering startup specializing in advanced bio-decontamination solutions. Originating from seven years of rigorous research at the Faculty of Sciences of the University of Lisbon, Delox has developed cutting-edge technologies aimed at eliminating harmful microorganisms. The company has created a solid formulation of hydrogen peroxide and faster aeration modules, which are integral to their next-generation bio-decontamination systems.

Delox serves a diverse range of clients across multiple sectors, including Health, Pharmaceuticals, Industry 4.0 (which refers to the current trend of automation and data exchange in manufacturing technologies), Biodefense, and Space Exploration. Their solutions are particularly valuable for environments that require stringent decontamination protocols to ensure safety and sterility.

Operating in the global bio-decontamination market, Delox's business model revolves around the development, testing, and commercialization of their innovative decontamination systems. They generate revenue through the sale of these systems, as well as through partnerships and collaborations with organizations that require advanced decontamination solutions. For instance, Delox has participated in military biological threat simulation exercises and is actively involved in space exploration initiatives, such as the Call to Orbit program.

The company has demonstrated the efficacy of its solutions through multiple field tests conducted in various settings, including military installations, pharmaceutical labs, and educational institutions in both Portugal and the USA. These successful tests have not only validated their technology but also led to continuous improvements in their products.

Delox has received several accolades, including the 2nd place at the Space Exploration Masters by the European Space Agency, Merck, and Airbus, and the Born from Knowledge prize by the National Innovation Agency. Their leadership team, comprising CEO Fadhil Musa, CTO Fernando Antunes, CSO Silva, and Non-Executive Chairman Michael Geanous, is committed to pushing the boundaries of bio-decontamination technology.

Keywords: bio-decontamination, hydrogen peroxide, health, pharmaceuticals, Industry 4.0, biodefense, space exploration, innovation, safety, sterility.